Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Applied and Environmental Microbiology,NikulinM.PasanenA
Diabetes 72 (Suppl
287 : 6571 Pascale A, Milano S, Corsico N, Lucchi L, Battaini F, Martelli EA et al
Even if biosimilar manufacturers succeed in invalidating the primary claims, individual indication patents could expose them to infringement suits on specific uses, creating a partial-market entry scenario where the biosimilar can be used for some indications but not others
US$ 23.29
US$ 25.82
US$ 29.78
US$ 23.17
US$ 29.12
US$ 27.76
US$ 27.39
US$ 29.02
US$ 25.61
US$ 24.80
US$ 28.96
